• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者抑郁和焦虑的管理

Depression and anxiety management in cirrhosis.

作者信息

Zimbrean Paula C, Jakab Simona S

机构信息

Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.

Department of Medicine (Digestive Disease), Yale School of Medicine, New Haven, Connecticut, USA.

出版信息

Hepatol Commun. 2024 Dec 11;9(1). doi: 10.1097/HC9.0000000000000600. eCollection 2025 Jan 1.

DOI:10.1097/HC9.0000000000000600
PMID:39670879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11637748/
Abstract

Depressive and anxiety symptoms are more prevalent in patients with cirrhosis compared to the general population. Between 2009 and 2019, the prevalence of depression in cirrhosis increased by 80%, while the prevalence of generalized anxiety disorder increased by over 400%. When present, anxiety and depression are linked to lower health-related quality of life, more severe symptoms (eg, fatigue), and poorer response to medical treatment. Screening instruments for depression and anxiety have shown acceptable validity in patients with cirrhosis. However, the diagnosis of depression and anxiety disorder remains challenging in this population and should follow the established criteria for general populations. Treatment interventions are numerous and include patient education and support around liver disease, pharmacological agents, and psychotherapy. Antidepressants are the treatment of choice for patients with depressive or anxiety disorder and cirrhosis. However, consideration must be given to dose adjustment and choice of agent due to changes in their metabolism in patients with liver disease. Psychotherapy may be used as a stand-alone therapy or concomitantly with pharmacotherapy. The high prevalence and complexity of depressive and anxiety symptoms in patients with cirrhosis support the integrated care approach in which patients are cared for by multidisciplinary teams.

摘要

与普通人群相比,肝硬化患者中抑郁和焦虑症状更为普遍。在2009年至2019年期间,肝硬化患者中抑郁症的患病率增加了80%,而广泛性焦虑症的患病率增加了400%以上。焦虑和抑郁症状一旦出现,就会与较低的健康相关生活质量、更严重的症状(如疲劳)以及对医疗治疗的较差反应相关联。用于筛查抑郁和焦虑的工具在肝硬化患者中已显示出可接受的有效性。然而,在这一人群中,抑郁和焦虑症的诊断仍然具有挑战性,应遵循针对普通人群的既定标准。治疗干预措施多种多样,包括围绕肝病的患者教育和支持、药物治疗以及心理治疗。抗抑郁药是患有抑郁或焦虑症及肝硬化患者的首选治疗药物。然而,由于肝病患者药物代谢的变化,必须考虑剂量调整和药物选择。心理治疗可以作为独立治疗方法使用,也可以与药物治疗同时进行。肝硬化患者中抑郁和焦虑症状的高患病率和复杂性支持采用多学科团队对患者进行护理的综合护理方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5cc/11637748/50db9bd4d3c9/hc9-9-e0600-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5cc/11637748/ef0374c27e27/hc9-9-e0600-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5cc/11637748/50db9bd4d3c9/hc9-9-e0600-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5cc/11637748/ef0374c27e27/hc9-9-e0600-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5cc/11637748/50db9bd4d3c9/hc9-9-e0600-g002.jpg

相似文献

1
Depression and anxiety management in cirrhosis.肝硬化患者抑郁和焦虑的管理
Hepatol Commun. 2024 Dec 11;9(1). doi: 10.1097/HC9.0000000000000600. eCollection 2025 Jan 1.
2
Sound mind vs sound heart.健全的心智与健全的心灵。
Br J Hosp Med (Lond). 2016 Mar;77(3):147-8, 169-71. doi: 10.12968/hmed.2016.77.3.147.
3
Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders.患有重度抑郁症和终生焦虑症的初级保健患者的治疗结果。
Am J Psychiatry. 1996 Oct;153(10):1293-300. doi: 10.1176/ajp.153.10.1293.
4
[Dissolving anxiety as an essential ingredient for any therapy].消除焦虑是任何治疗的关键要素。
Orv Hetil. 2014 Jun 1;155(22):859-64. doi: 10.1556/OH.2014.29925.
5
[Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].[私人执业精神科门诊患者中的焦虑症:患病率、共病情况及负担(DELTA研究)]
Encephale. 2002 Nov-Dec;28(6 Pt 1):510-9.
6
Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment.重度抑郁症和广泛性焦虑症的心理治疗:一项卫生技术评估
Ont Health Technol Assess Ser. 2017 Nov 13;17(15):1-167. eCollection 2017.
7
Psychological therapies for treatment-resistant depression in adults.成人难治性抑郁症的心理治疗
Cochrane Database Syst Rev. 2018 May 14;5(5):CD010558. doi: 10.1002/14651858.CD010558.pub2.
8
Generalized anxiety disorder screening scores are associated with greater treatment need among Veterans with depression.广泛性焦虑障碍筛查评分与抑郁症退伍军人的治疗需求增加相关。
J Psychiatr Res. 2024 Sep;177:31-38. doi: 10.1016/j.jpsychires.2024.07.003. Epub 2024 Jul 3.
9
[Follow-up study of quality of life and treatment of eating disorder: dynamics of the depressive and anxiety symptoms].饮食失调的生活质量与治疗随访研究:抑郁和焦虑症状的动态变化
Psychiatr Pol. 2002 Nov-Dec;36(6 Suppl):323-9.
10
[Anxiety and depression in the elderly].[老年人的焦虑与抑郁]
Z Psychosom Med Psychother. 2012;58(4):336-56. doi: 10.13109/zptm.2012.58.4.336.

引用本文的文献

1
Identification of immune and major depressive disorder-related diagnostic markers for early nonalcoholic fatty liver disease by WGCNA and machine learning.通过加权基因共表达网络分析(WGCNA)和机器学习识别早期非酒精性脂肪性肝病的免疫和重度抑郁症相关诊断标志物
Front Bioinform. 2025 Jun 26;5:1594971. doi: 10.3389/fbinf.2025.1594971. eCollection 2025.
2
Tides of emotion: Hepatologists' role in navigating depression and anxiety in liver disease.情绪的浪潮:肝病专家在应对肝病患者抑郁和焦虑方面的作用
Hepatol Commun. 2025 Jul 14;9(8). doi: 10.1097/HC9.0000000000000741. eCollection 2025 Aug 1.

本文引用的文献

1
Change in suicidal ideation, depression, and anxiety following collaborative care in the community.社区协作式护理对自杀意念、抑郁和焦虑的影响变化。
BMC Prim Care. 2024 Jul 5;25(1):241. doi: 10.1186/s12875-024-02494-2.
2
The burden of significant pain in the cirrhosis population: Risk factors, analgesic use, and impact on health care utilization and clinical outcomes.肝硬化患者中严重疼痛的负担:风险因素、镇痛药物的使用,以及对医疗保健利用和临床结局的影响。
Hepatol Commun. 2024 May 22;8(6). doi: 10.1097/HC9.0000000000000432. eCollection 2024 Jun 1.
3
Confirmatory validation of the patient health questionnaire - 4 (PHQ-4) for gastrointestinal disorders: A large-scale cross-sectional survey.
患者健康问卷-4(PHQ-4)用于胃肠道疾病的验证性验证:一项大规模横断面调查。
J Psychosom Res. 2024 May;180:111654. doi: 10.1016/j.jpsychores.2024.111654. Epub 2024 Mar 30.
4
Meta-analysis of the comparative efficacy of benzodiazepines and antidepressants for psychic versus somatic symptoms of generalized anxiety disorder.广泛性焦虑障碍精神躯体症状的苯二氮䓬类药物和抗抑郁药比较疗效的荟萃分析。
Compr Psychiatry. 2024 Jul;132:152479. doi: 10.1016/j.comppsych.2024.152479. Epub 2024 Mar 24.
5
A Systematic Review of Interventions for Demoralization in Patients with Chronic Diseases.慢性病患者士气低落干预措施的系统评价
Int J Behav Med. 2025 Feb;32(1):1-10. doi: 10.1007/s12529-024-10262-w. Epub 2024 Feb 5.
6
Histopathological examination of characteristic brain MRI findings in acute hyperammonemic encephalopathy: A case report and review of the literature.急性高氨血症性脑病特征性脑 MRI 表现的组织病理学检查:病例报告及文献复习。
Neuroradiol J. 2024 Oct;37(5):630-635. doi: 10.1177/19714009231212370. Epub 2023 Nov 1.
7
Effects of Psychological Nursing Combined with Comprehensive Nursing on Gastrointestinal Bleeding and Nutritional Status in Cirrhosis.心理护理联合综合护理对肝硬化患者胃肠出血及营养状况的影响。
Altern Ther Health Med. 2024 Jan;30(1):318-325.
8
Disparities in Liver Transplantation Rates and Outcomes Among Adults with and without Mental Illnesses.精神疾病患者和非精神疾病患者的肝移植率和结局存在差异。
J Gastrointest Surg. 2023 Nov;27(11):2434-2443. doi: 10.1007/s11605-023-05814-6. Epub 2023 Aug 31.
9
Hepatocellular carcinoma surveillance may be associated with potential psychological harms in patients with cirrhosis.肝细胞癌监测可能会给肝硬化患者带来潜在的心理伤害。
Hepatology. 2024 Jan 1;79(1):107-117. doi: 10.1097/HEP.0000000000000528. Epub 2023 Jul 4.
10
Depression and Anxiety Symptoms in Patients With Cirrhosis: A Prospective Study Before and After Liver Transplantation.肝硬化患者的抑郁和焦虑症状:肝移植前后的前瞻性研究。
Transplant Proc. 2023 Sep;55(7):1644-1648. doi: 10.1016/j.transproceed.2023.04.040. Epub 2023 Jul 1.